CRO

Alkermes says API demand is safe; Oxygen taps PPD for Phase IIb;

> Alkermes ($ALKS) says the CMO demand for highly potent APIs can withstand Big Pharma in-sourcing. Article

> CROs need to diversify to survive, according to Catalyst Corporate Finance, as the market favors operations that can fill as many R&D roles as possible. Story

> Outsourcing-Pharma held a reader poll to determine just what "CRO" stands for in the minds of industry players. More

> Oxygen Biotherapeutics ($OXBT) has tapped PPD to conduct a Phase IIb clinical trial for Oxycyte, a brain injury treatment. News

> Icon ($ICLR) has reached out to Wingspan Technology for its cloud-based clinical trial system. Item

> CRO Onyx Scientific has named Dan Brisard its business development director. Release